Longitudinal analysis of serum alpha-fetoprotein in stable and progressive metastatic pancreatic neuroendocrine tumours
AFP consistently increases in patients with progressive pancreatic NETs compared to patients with stable disease on baseline. Potential utility of AFP measurements requires further follow-up studies, especially as a prognostic biomarker.
Authors
- Jan Musiałkiewicz (ORCID: https://orcid.org/0009-0002-2449-3324)
- Marek A. Ruchała (ORCID: https://orcid.org/0000-0001-9743-2405)
- Paweł Gut (ORCID: https://orcid.org/0000-0002-1661-175X)
- Bartłomiej Budny (ORCID: https://orcid.org/0000-0002-2860-395X)
- Paweł Komarnicki (ORCID: https://orcid.org/0000-0001-6548-0613)
- Adam Maciejewski (ORCID: https://orcid.org/0000-0002-5381-3211)
- Joanna Jadwiga Sienkiewicz
- Phantira Sirisachadecha
Institutions
- Poznan University of Medical Sciences (PL)
Publication Details
- Journal
- Endocrine Connections
- Published
- 2025-08-29
- DOI
- https://doi.org/10.1530/ec-25-0350
- Citations
- 1
- Primary Topic
- Neuroendocrine Tumor Research Advances
- Type
- article
- Field-Weighted Citation Impact
- 1.35